Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRV | KRRO | DOMH | ||
| Company | Acrivon Therapeutics Inc | Korro Bio Inc | Dominari Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.37 | 8.35 | 4.51 | ||
| High | 2.50 | 8.40 | 4.64 | ||
| Low | 2.32 | 8.00 | 4.40 | ||
| Latest | 2.44 | 8.12 | 4.57 | ||
| Change | +0.05 | -0.29 | +0.05 | ||
| % Change | +2.09% | -3.45% | +1.11% | ||
| Volume | 181,100 | 99,800 | 211,400 | ||
| 20-Day Average Volume | 454,845 | 346,255 | 320,945 | ||
| Previous Close | 2.39 | 8.41 | 4.52 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.40 | 7.40 | 4.36 | ||
| 20-Day Raw Stochastic | 52.46% | 80.42% | 62.36% | ||
| 20-Day Relative Strength | 55.15 | 34.48 | 48.28 | ||
| Weighted Alpha | +13.27 | -7.75 | -21.63 | ||
| Today's Opinion | 96% Buy | 72% Sell | 72% Sell | ||
| Previous Opinion | 80% Buy | 72% Sell | 72% Sell | ||
| Last Month's Opinion | 72% Buy | 40% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.96% since 12/18/25 | +3.84% since 12/18/25 | +1.11% since 12/18/25 | ||
| Low | 2.12 on 12/19/25 | 7.75 on 12/19/25 | 4.20 on 12/24/25 | ||
| High | 2.50 on 12/26/25 | 8.59 on 12/24/25 | 4.70 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | +3.39% since 11/26/25 | +47.10% since 11/26/25 | -2.14% since 11/26/25 | ||
| Low | 2.12 on 12/19/25 | 5.20 on 12/02/25 | 3.72 on 12/05/25 | ||
| High | 2.73 on 12/11/25 | 8.83 on 12/12/25 | 5.08 on 12/11/25 | ||
| 3-Month | |||||
| %Chg | +46.99% since 09/26/25 | -80.03% since 09/26/25 | -33.19% since 09/26/25 | ||
| Low | 1.66 on 09/29/25 | 5.20 on 12/02/25 | 3.72 on 12/05/25 | ||
| High | 2.73 on 12/11/25 | 55.89 on 10/16/25 | 7.54 on 10/06/25 | ||
| 6-Month | |||||
| %Chg | +86.26% since 06/26/25 | -34.20% since 06/26/25 | -22.54% since 06/26/25 | ||
| Low | 1.15 on 07/01/25 | 5.20 on 12/02/25 | 3.72 on 12/05/25 | ||
| High | 2.73 on 12/11/25 | 55.89 on 10/16/25 | 8.40 on 09/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 75,416 | 79,199 | 72,374 | ||
| Shares Outstanding, K | 31,555 | 9,417 | 16,012 | ||
| Annual Sales | 0 | 2,270,000 | 18,150,000 | ||
| Annual Net Income | -80,560,000 | -83,580,000 | -14,700,000 | ||
| Last Quarter Sales | 0 | 1,090,000 | 50,820,000 | ||
| Last Quarter Net Income | -18,230,000 | -18,060,000 | 125,210,000 | ||
| 60-Month Beta | 1.75 | 3.03 | 0.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 11/13/25 | -1.92 on 11/12/25 | -0.11 on 11/10/25 | ||
| Latest Earnings Date | 03/26/26 | 03/17/26 | 04/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||